Vor Biopharma, Inc. (VOR)
13.72
-1.00
(-6.79%)
USD |
NASDAQ |
Dec 29, 16:00
13.70
-0.02
(-0.15%)
After-Hours: 20:00
Vor Biopharma Cash from Investing (Quarterly): -0.244M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Outset Medical, Inc. | 2.967M |
| iBio, Inc. | -21.49M |
| Salarius Pharmaceuticals, Inc. | -0.20M |
| Senti Biosciences, Inc. | 0.00 |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -53.66M |
| Cash from Financing (Quarterly) | 21.55M |
| Free Cash Flow | -144.67M |
| Free Cash Flow Per Share (Quarterly) | -8.068 |
| Free Cash Flow to Equity (Quarterly) | -56.96M |
| Free Cash Flow to Firm (Quarterly) | -53.91M |
| Free Cash Flow Yield | -29.86% |